Grant of Restricted Stock Units to Management and Employees and Grant of Warrants to Employees in Genmab

Core Points - Genmab A/S announced the granting of 614,676 restricted stock units and 517,191 warrants to management and employees [1] - The fair value of each restricted stock unit is DKK 1,608.50, while the exercise price for each warrant is also DKK 1,608.50 [1][3] - The restricted stock units will vest after three years, and the warrants will vest three years after the grant date, expiring at the seventh anniversary [2][4] Restricted Stock Units - Each restricted stock unit provides a conditional right to receive one share of Genmab A/S of nominally DKK 1 [1] - Vesting of restricted stock units for executive management is subject to performance criteria [1] - The fair value of each restricted stock unit is based on the closing market price on the date of grant [1] Warrants - Each warrant entitles the owner to subscribe for one share of nominally DKK 1, subject to payment of the exercise price [3] - The fair value of each warrant, calculated using the Black-Scholes formula, is DKK 501.65 [3] - The new warrants are granted under the terms set out in the warrant program adopted by the Board of Directors [4] Company Overview - Genmab is an international biotechnology company focused on improving patient lives through innovative antibody therapeutics [5] - The company has a proprietary pipeline that includes bispecific T-cell engagers and next-generation immune checkpoint modulators [5] - Genmab aims to transform the lives of people with cancer and other serious diseases with its antibody medicines by 2030 [5]